CARDIAC EFFECTS OF ISOLIQUIRITIGENIN

Citation
Jw. Wegener et H. Nawrath, CARDIAC EFFECTS OF ISOLIQUIRITIGENIN, European journal of pharmacology, 326(1), 1997, pp. 37-44
Citations number
33
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00142999
Volume
326
Issue
1
Year of publication
1997
Pages
37 - 44
Database
ISI
SICI code
0014-2999(1997)326:1<37:CEOI>2.0.ZU;2-I
Abstract
The effects of isoliquiritigenin on force of contraction (F-c), L-type Ca2+ current (I-CA) and intracellular Ca2+ concentration ([Ca2+](i)) were investigated in rat ventricular heart muscle. Isoliquiritigenin i ncreased F-c and I-Ca and, after longer exposure times, resting tensio n and [Ca2+](i). The effect of isoliquiritigenin (100 mu M) on I-Ca wa s diminished by Rp-cAMPS (30 mu M). 1H-[1,2,4]oxa-diazolo[4,3-a]quinox alin-1-one (50 mu M) did not influence the effects of isoliquiritigeni n on F-c and I-Ca. The positive inotropic effects of isoprenaline and forskolin, but not of 3-isobutyl-1-methylxanthine, were potentiated by isoliquiritigenin (100 mu M). In the presence of milrinone (10 mu M), no further effects of isoliquiritigenin (100 mu M) on F-c and I-Ca we re observed. It is suggested that the increase in F-c and I-Ca by isol iquiritigenin is due to an accumulation of cyclic AMP. These effects a re probably unrelated to an effect of the drug on soluble guanylyl cyc lase, as reported for smooth muscle, but rather due to a direct inhibi tion of phosphodiesterase III activity.